Showing results (1041-1050 of 1,140) with videos related to

Sort By:
Pageof 114
The New England Journal of Medicine|January 27, 2021
Resumption of Cardiac Activity after Withdrawal of Life-Sustaining MeasuresSonny Dhanani, Laura Hornby, Amanda van Beinum, et al.
Clinical Colorectal Cancer|November 8, 2011
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancerLeonard Saltz, Suprith Badarinath, Shaker Dakhil, et al.
JAMA|October 22, 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical TrialJeannie Callum, Michael E Farkouh, Damon C Scales, et al.
BMJ (Clinical Research Ed.)|May 6, 2021
Suicide and self-harm in adult survivors of critical illness: population based cohort studyShannon M Fernando, Danial Qureshi, Manish M Sood, et al.
Anesthesiology|March 16, 2018
Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials: Universal Definition of Perioperative Bleeding in Cardiac Surgery and European Coronary Artery Bypass Grafting Bleeding Severity GradeJustyna Bartoszko, Duminda N Wijeysundera, Keyvan Karkouti, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2017
Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical OutcomesEwan C Goligher, Martin Dres, Eddy Fan, et al.
JAMA Ophthalmology|July 18, 2024
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical TrialSunil K Srivastava, Timothy R Watkins, Quan Dong Nguyen, et al.
Plos Genetics|May 11, 2018
Analysis of motor dysfunction in Down Syndrome reveals motor neuron degenerationSheona Watson-Scales, Bernadett Kalmar, Eva Lana-Elola, et al.
Chest|February 3, 2023
Epinephrine in Out-of-Hospital Cardiac Arrest: A Network Meta-analysis and Subgroup Analyses of Shockable and Nonshockable RhythmsShannon M Fernando, Rebecca Mathew, Behnam Sadeghirad, et al.
Molecular Cancer Therapeutics|January 30, 2016
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian CancerColin D Weekes, Laetitia E Lamberts, Mitesh J Borad, et al.
Pageof 114